1975
DOI: 10.1038/bjc.1975.80
|View full text |Cite
|
Sign up to set email alerts
|

Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line

Abstract: Our studies of the cytotoxic drug, bleomycin, have shown Bleehen, 1973, 1975) that in early plateau phase the sensitivity is reduced from that shown by exponentially growing cells. In late plateau phase, however, the sensitivity increases again and becomes greater than that of exponential phase cells. In this paper we report results obtained in exponential, early plateau and late plateau phases for 5 other cVtotoxic drugs. MATERIALS AND METHODSFull details of the cell line and of the drug response assay have b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
15
1

Year Published

1977
1977
1994
1994

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 9 publications
4
15
1
Order By: Relevance
“…The other intercalating agent studied, doxorubicin, also shows higher activity against exponential than against plateau-phase cultures (Figure 4b), as has been demonstrated with EMT6 (Twentyman & Bleehen, 1975;Kwok & Twentyman, 1985), CHO (Barranco & Novak, 1974), L1210 (Bhuyan et al, 1977) and LoVo (Drewinko et al, 1981) cells. Such cycle selectivity of intercalating drugs appears to reflect the activity of topoisomerase II, which declines in noncycling cells (Sullivan et al, 1986).…”
Section: Discussionsupporting
confidence: 57%
See 3 more Smart Citations
“…The other intercalating agent studied, doxorubicin, also shows higher activity against exponential than against plateau-phase cultures (Figure 4b), as has been demonstrated with EMT6 (Twentyman & Bleehen, 1975;Kwok & Twentyman, 1985), CHO (Barranco & Novak, 1974), L1210 (Bhuyan et al, 1977) and LoVo (Drewinko et al, 1981) cells. Such cycle selectivity of intercalating drugs appears to reflect the activity of topoisomerase II, which declines in noncycling cells (Sullivan et al, 1986).…”
Section: Discussionsupporting
confidence: 57%
“…Since Bruce and his associates (reviewed by Valeriote & van Putten, 1975;van Putten, 1974) first demonstrated the importance of proliferative state in relation to drug sensitivity in vivo, most studies have utilized in vitro models of non-cycling cells such as plateau-phase cultures (Barranco & Novak, 1974;Drewinko et al, 1981;Hahn & Little, 1972;Twentyman & Bleehen, 1975) and multicellular spheroids (Sutherland & Durand, 1984;Nederman & Twentyman, 1984;Kwok & Twentyman, 1985). The question remains as to whether these provide adequate models for non-cycling cells in tumours (Valeriote & van Putten, 1975;Twentyman & Bleehen, 1975).…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Unlike EMT6 cells which are more sensitive to HN2 in exponential than in plateau phase (Twentyman & Bleehen, 1975) In addition to possible differences in initial sensitivity of isolated spheriod cells and cells in intact spheroids to drugs, an additional factor comes into operation when considering the relationship between cellular response and the "overall' response of intact spheroids. "Recovery of potentially lethal damage" by cells in drug-treated EMT6 spheroids was reported by Twentyman (1980).…”
Section: Resultsmentioning
confidence: 99%